Skip to main content
SpringerLink
Log in

Analgosedierung in der Intensivmedizin

  • Chapter
NeuroIntensiv

  • 3813 Accesses

Zusammenfassung

Das Bild analgosedierter Patienten auf einer Intensivstation hat sich in den letzten Jahrzehnten grundlegend verändert. Dazu haben neue, besser geeignete Medikamente für die Analgosedierung beigetragen, aber auch eine deutlich diff erenziertere Beatmungstherapie von kritisch Kranken. Während noch vor wenigen Jahren Patienten auf Intensivstationen im Wesentlichen tief sediert und nicht kooperationsfähig waren, setzt sich zunehmend die Erkenntnis durch, dass der Bewusstseinsgrad eines Patienten nur soweit eingeschränkt sein sollte, wie es im Rahmen des zugrundeliegenden Krankheitsbildes und der entsprechenden Therapie erforderlich ist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 3423:1471–1477

    Article  Google Scholar 

  2. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371:126–134

    Article  PubMed  Google Scholar 

  3. Elliott MW, Confalonieri M, Nava S. Where to perform noninvasive ventilation? Eur Respir J 2002; 19:1159–1166

    Article  PubMed  CAS  Google Scholar 

  4. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119–141

    Article  PubMed  Google Scholar 

  5. Martin J, Heymann A, Basell K, et al. Evidence and consensusbased German guidelines for the management of analgesia, sedation and delirium in intensive care-short version. Ger Med Sci 2010; 8:Doc02

    Google Scholar 

  6. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. Jama 2004; 291:1753–1762

    Article  PubMed  CAS  Google Scholar 

  7. Milbrandt EB, Deppen S, Harrison PL, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004; 32:955–962

    Article  PubMed  Google Scholar 

  8. Girard TD, Pandharipande PP, Ely EW. Delirium in the intensive care unit. Crit Care 2008; 12 (Suppl 3):S3

    PubMed  Google Scholar 

  9. Schweickert WD, Pohlman MC, Pohlman AS et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009; 373:1874–1882

    Article  PubMed  Google Scholar 

  10. Werner C. Effects of analgesia and sedation on cerebrovascular circulation, cerebral blood volume, cerebral metabolism and intracranial pressure. Anaesthesist 1995; 44 (Suppl 3):S566–572

    PubMed  CAS  Google Scholar 

  11. Prause A, Wappler F, Scholz J, et al. Respiratory depression under long-term sedation with sufentanil, midazolam and clonidine has no clinical significance. Intensive Care Med 2000; 26:1454–1461

    Article  PubMed  CAS  Google Scholar 

  12. Monk JP, Beresford R, Ward A. Sufentanil. A review of its pharmacological properties and therapeutic use. Drugs 1988; 36:286–313

    Article  PubMed  CAS  Google Scholar 

  13. Wappler F, Scholz J, Prause A, et al. [Level concept of analgesic dosing in intensive care medicine with sufentanil]. Anasthesiol Intensivmed Notfallmed Schmerzther 1998; 33:8–26

    PubMed  CAS  Google Scholar 

  14. Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, shortacting, mu-opioid. Anesth Analg 1996; 83:646–651

    PubMed  CAS  Google Scholar 

  15. Scholz J, Steinfath M. Is remifentanil an ideal opioid for anesthesiologic management in the 21st century? Anasthesiol Intensivmed Notfallmed Schmerzther 1996; 31:592–607

    Article  PubMed  CAS  Google Scholar 

  16. Wilhelm W, Biedler A, Larsen R. Remifentanil. Early clinical experiences with 3100 patients. Anaesthesist 1997; 46:992–997

    Article  PubMed  CAS  Google Scholar 

  17. Wilhelm W, Dorscheid E, Schlaich N, et al. The use of remifentanil in critically ill patients. Clinical findings and early experience. Anaesthesist 1999; 48:625–629

    Article  PubMed  CAS  Google Scholar 

  18. Tipps LB, Coplin WM, Murry KR, Rhoney DH. Safety and feasibility of continuous infusion of remifentanil in the neurosurgical intensive care unit. Neurosurgery 2000; 46:596–601; discussion-2

    Article  PubMed  CAS  Google Scholar 

  19. Fodale V, Schifilliti D, Pratico C, Santamaria LB. Remifentanil and the brain. Acta Anaesthesiol Scand 2008; 52:319–326

    Article  PubMed  CAS  Google Scholar 

  20. Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet 1998; 35:49–64

    Article  PubMed  CAS  Google Scholar 

  21. Tonner PH, Kampen J, Scholz J. Pathophysiological changes in the elderly. Best Pract Res Clin Anaesthesiol 2003; 17:163–177

    Article  PubMed  Google Scholar 

  22. Young C, Knudsen N, Hilton A, Reves JG. Sedation in the intensive care unit. Crit Care Med 2000; 28:854–866

    Article  PubMed  CAS  Google Scholar 

  23. Young CC, Prielipp RC. Benzodiazepines in the intensive care unit. Crit Care Clin 2001; 17:843–862

    Article  PubMed  CAS  Google Scholar 

  24. Barr J, Zomorodi K, Bertaccini EJ, et al. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 2001; 95:286–298

    Article  PubMed  CAS  Google Scholar 

  25. Ariano RE, Kassum DA, Aronson KJ. Comparison of sedative recovery time after midazolam versus diazepam administration. Crit Care Med 1994; 22:1492–1496

    Article  PubMed  CAS  Google Scholar 

  26. Pandharipande P, Shintani A, Peterson J et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006; 104:21–26

    Article  PubMed  CAS  Google Scholar 

  27. Walder B, Tramer MR, Seeck M. Seizure-like phenomena and propofol: a systematic review. Neurology 2002; 58:1327–1332

    PubMed  Google Scholar 

  28. Jackson JC, Gordon SM, Hart RP, et al. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev 2004; 14:87–98

    Article  PubMed  Google Scholar 

  29. Hans P, Bonhomme V. Why we still use intravenous drugs as the basic regimen for neurosurgical anaesthesia. Curr Opin Anaesthesiol 2006; 19:498–503

    Article  PubMed  Google Scholar 

  30. Ludbrook GL, Visco E, Lam AM. Propofol: Relation between Brain Concentrations, Electroencephalogram, Middle Cerebral Artery Blood Flow Velocity, and Cerebral Oxygen Extraction during Induction of Anesthesia. Anesthesiology 2002; 97:1363–1370

    Article  PubMed  CAS  Google Scholar 

  31. Kaisti KK, Metsahonkala L, Teras M, et al. Effects of surgical levels of propofol and sevoflurane anesthesia on cerebral blood flow in healthy subjects studied with positron emission tomography. Anesthesiology 2002; 96:1358–1370

    Article  PubMed  CAS  Google Scholar 

  32. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8:491–499

    Article  PubMed  CAS  Google Scholar 

  33. Parke TJ, Stevens JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. Bmj 1992; 305:613–616

    Article  PubMed  CAS  Google Scholar 

  34. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003; 29:1417–1425

    Article  PubMed  Google Scholar 

  35. Arzneimittelkommission der deutschen Ärzteschaft. Schwere unerwünsche Arzneimittelwirkungen nach Propofol-Infusionen zur Sedierung. Dtsch. Ärztebl. 2004; 50:A3447

    Google Scholar 

  36. Roberts I. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev 2000:CD000033

    Google Scholar 

  37. Engelhard K, Werner C. Überwachung und Therapie des erhöhten intrakraniellen Drucks. Anaesthesiol Intensivmed 2008; 49:258–268

    Google Scholar 

  38. Brain Trauma Foundation. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007; 24 (Suppl 1):S1–106

    Article  Google Scholar 

  39. Schalen W, Sonesson B, Messeter K, et al. Clinical outcome and cognitive impairment in patients with severe head injuries treated with barbiturate coma. Acta Neurochir (Wien) 1992; 117:153–159

    Article  CAS  Google Scholar 

  40. Hudetz JA, Pagel PS. Neuroprotection by ketamine: a review of the experimental and clinical evidence. J Cardiothorac Vasc Anesth 2010; 24:131–142

    Article  PubMed  CAS  Google Scholar 

  41. Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury? Anesth Analg 2005; 101:524–534, table of contents

    Article  PubMed  CAS  Google Scholar 

  42. Huang C, Long H, Shi YS, et al. Ketamine enhances the efficacy to and delays the development of tolerance to electroacupuncture-induced antinociception in rats. Neurosci Lett 2005; 375:138–142

    Article  PubMed  CAS  Google Scholar 

  43. Subramaniam B, Subramaniam K, Pawar DK, Sennaraj B. Preoperative epidural ketamine in combination with morphine does not have a clinically relevant intra- and postoperative opioid-sparing effect. Anesth Analg 2001; 93:1321–1326

    Article  PubMed  CAS  Google Scholar 

  44. Dorman T, Clarkson K, Rosenfeld BA et al. Effects of clonidine on prolonged postoperative sympathetic response. Crit Care Med 1997; 25:1147–1152

    Article  PubMed  CAS  Google Scholar 

  45. Koide T, Wieloch TW, Siesjo BK. Circulating catecholamines modulate ischemic brain damage. J Cereb Blood Flow Metab 1986; 6:559–565

    Article  PubMed  CAS  Google Scholar 

  46. Globus MY, Busto R, Dietrich WD et al. Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia. J Cereb Blood Flow Metab 1989; 9:892–896

    Article  PubMed  CAS  Google Scholar 

  47. Gustafson I, Westerberg EJ, Wieloch T. Extracellular brain cortical levels of noradrenaline in ischemia: effects of desipramine and postischemic administration of idazoxan. Exp Brain Res 1991; 86:555–561

    Article  PubMed  CAS  Google Scholar 

  48. Miyazaki M, Nazarali AJ, Boisvert DP et al. Inhibition of ischemiainduced brain catecholamine alterations by clonidine. Brain Res Bull 1989; 22:207–211

    Article  PubMed  CAS  Google Scholar 

  49. Spies CD, Dubisz N, Neumann T et al. Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Crit Care Med 1996; 24:414–422

    Article  PubMed  CAS  Google Scholar 

  50. Paris A, Mantz J, Tonner PH et al. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. Anesth Analg 2006; 102:456–461

    Article  PubMed  CAS  Google Scholar 

  51. Dahmani S, Rouelle D, Gressens P, Mantz J. Characterization of the postconditioning effect of dexmedetomidine in mouse organotypic hippocampal slice cultures exposed to oxygen and glucose deprivation. Anesthesiology 2010; 112:373–383

    Article  PubMed  CAS  Google Scholar 

  52. Aryan HE, Box KW, Ibrahim D, et al. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj 2006; 20:791–798

    Article  PubMed  Google Scholar 

  53. Vayer P, Mandel P, Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 1987; 41:1547–1557

    Article  PubMed  CAS  Google Scholar 

  54. Feigenbaum JJ, Howard SG. Gamma hydroxybutyrate is not a GABA agonist. Prog Neurobiol 1996; 50:1–7

    Article  PubMed  CAS  Google Scholar 

  55. Okun MS, Boothby LA, Bartfield RB, Doering PL. GHB: an important pharmacologic and clinical update. J Pharm Pharm Sci 2001; 4:167–175

    PubMed  CAS  Google Scholar 

  56. Martin J, Bäsell K, Bürkle H, et al. Analgesie und Sedierung in der Intensivmedizin - Kurzversion. S2-Leitlinien der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin. Anästh Intensivmed 2005; 46:S1–20

    Google Scholar 

  57. Sessler CN, Gosnell MS, Grap MJ et al. The Richmond Agitation- Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166:1338–1344

    Article  PubMed  Google Scholar 

  58. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). Jama 2003; 289:2983–2991

    Article  PubMed  Google Scholar 

  59. Johansen JW, Sebel PS. Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiology 2000; 93:1336–1344

    Article  PubMed  CAS  Google Scholar 

  60. Bruhn J, Bouillon TW, Radulescu L, et al. Correlation of approximate entropy, bispectral index, and spectral edge frequency 95 (SEF95) with clinical signs of "anesthetic depth" during coadministration of propofol and remifentanil. Anesthesiology 2003; 98:621–627

    Article  PubMed  CAS  Google Scholar 

  61. Tonner PH, Wei C, Bein B, et al. Comparison of two bispectral index algorithms in monitoring sedation in postoperative intensive care patients. Crit Care Med 2005; 33:580–584

    Article  PubMed  Google Scholar 

  62. Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology 1998; 89:980–1002

    Article  PubMed  CAS  Google Scholar 

  63. Gan TJ, Glass PS, Windsor A et al. Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. BIS Utility Study Group. Anesthesiology 1997; 87:808–815

    Article  PubMed  CAS  Google Scholar 

  64. De Deyne C, Struys M, Decruyenaere J, et al. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients. Intensive Care Med 1998; 24:1294–1298

    Article  PubMed  Google Scholar 

  65. Simmons LE, Riker RR, Prato BS, Fraser GL. Assessing sedation during intensive care unit mechanical ventilation with the Bispectral Index and the Sedation-Agitation Scale. Crit Care Med 1999; 27:1499–1504

    Article  PubMed  CAS  Google Scholar 

  66. Riker RR, Fraser GL, Simmons LE, Wilkins ML. Validating the Sedation-Agitation Scale with the Bispectral Index and Visual Analog Scale in adult ICU patients after cardiac surgery. Intensive Care Med 2001; 27:853–858

    Article  PubMed  CAS  Google Scholar 

  67. Riess ML, Graefe UA, Goeters C, et al. Sedation assessment in critically ill patients with bispectral index. Eur J Anaesthesiol 2002; 19:18–22

    PubMed  CAS  Google Scholar 

  68. Bruhn J, Ropcke H, Hoeft A. Approximate entropy as an electroencephalographic measure of anesthetic drug effect during desflurane anesthesia. Anesthesiology 2000; 92:715–726

    Article  PubMed  CAS  Google Scholar 

  69. Nasraway SS, Jr., Wu EC, Kelleher RM, et al. How reliable is the Bispectral Index in critically ill patients? A prospective, comparative, single-blinded observer study. Crit Care Med 2002; 30:1483–1487

    Article  Google Scholar 

  70. Tonner PH, Weiler N, Paris A, Scholz J. Sedation and analgesia in the intensive care unit. Curr Opin Anaesthesiol 2003; 16:113–121

    Article  PubMed  Google Scholar 

  71. Kawaguchi M, Furuya H, Patel PM. Neuroprotective effects of anesthetic agents. J Anesth 2005; 19:150–156

    Article  PubMed  Google Scholar 

  72. Timofeev I, Hutchinson PJ. Outcome after surgical decompression of severe traumatic brain injury. Injury 2006; 37:1125–1132

    Article  PubMed  CAS  Google Scholar 

  73. Patel HC, Menon DK, Tebbs S, et al. Specialist neurocritical care and outcome from head injury. Intensive Care Med 2002; 28:547–553

    Article  PubMed  Google Scholar 

  74. Kraus JJ, Metzler MD, Coplin WM. Critical care issues in stroke and subarachnoid hemorrhage. Neurol Res 2002; 24 (Suppl 1):S47–57

    Article  PubMed  Google Scholar 

  75. Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999; 91:750–760

    Article  PubMed  CAS  Google Scholar 

  76. Siffleet J, Young J, Nikoletti S, Shaw T. Patients' self-report of procedural pain in the intensive care unit. J Clin Nurs 2007; 16:2142–2148

    Article  PubMed  Google Scholar 

  77. Enblad P, Nilsson P, Chambers I, et al. R3-survey of traumatic brain injury management in European Brain IT centres year 2001. Intensive Care Med 2004; 30:1058–1065

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Anästhesie, Op. und Allg. Intensivmedizin, Notfallmedizin Klinikum Links der Weser, Senator-Weßling-Str. 1, 28277, Bremen

    Prof. Dr. P. H. Tonner

  2. Rathochstr. 46a, 81247, München

    Dr. E. M. Schaffrath

Authors
  1. Prof. Dr. P. H. Tonner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. E. M. Schaffrath
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen

    Stefan Schwab

  2. Benediktuskrankenhaus, Neurologische Klinik und Geriatrie Johannes Wesling Klinikum Minden, Hans-Nolte-Str. 1, 32429, Minden

    Peter Schellinger

  3. Klinik für Anästhesiologie, Klinikum der Johannes Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131, Mainz

    Christian Werner

  4. Neurochirurgische Klinik, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg

    Andreas Unterberg  & Werner Hacke  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tonner, P.H., Schaffrath, E.M. (2012). Analgosedierung in der Intensivmedizin. In: Schwab, S., Schellinger, P., Werner, C., Unterberg, A., Hacke, W. (eds) NeuroIntensiv. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16911-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16911-3_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16910-6

  • Online ISBN: 978-3-642-16911-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation